Testicular Cancer Conference Boston 2025
Mass General Brigham
Dana Farber Cancer Institute
Harvard University
Joseph B. Martin Conference Center at Harvard Medical School
Presented by fennec pharmaceuticals
September 25-27, 2025
We look forward to hosting our 2025 Testicular Cancer Conference in Boston, Massachusetts thanks to Mass General Brigham, Dana Farber Cancer Institute and Harvard University.
Watch the recap of last year’s conference!
Group photo from the dinner social at our 2024 Testicular Cancer Conference presented by Fennec Pharmaceuticals.
Bringing Survivors, Patients, Caregivers, and Medical Experts Together
We are focused on bringing an international group of TC patients, survivors and their loved ones together to address the physical and emotional toll of being diagnosed and treated for a cancer at a young age. We discuss life with and after cancer, and lifestyle changes that can help the healing process. We invite a panel of medical experts to provide pertinent information for patients currently fighting and resources for long-term survivorship. TCAF provides attendees with information and resources to advocate within their community about the importance of early detection.
Presentation & Breakout Topics:
To be announced.
Guest Speakers:
To be announced.
Lead Chair for this year’s conference:
Dr. Timothy Clinton - Brigham’s & Women’s Hospital - Mass General Brigham
Dr. Clinton’s clinical interests are in the treatment of all genitourinary malignancies with a focus on urothelial carcinoma and testicular cancer utilizing both open and robotic approaches. His research interests are defining the genomic determinants of urothelial carcinoma and germ cell tumors.
Thank you to our title sponsor:
Fennec Pharmaceuticals is a biotechnology company dedicated to improving the lives of adolescent and young adult testicular cancer patients who are treated with cisplatin to reduce the risk of hearing loss.